Browsing Tag
Japan
223 posts
Can Leifras’ $4 IPO survive Nasdaq volatility? Inside the Japanese education firm’s bold U.S. gamble
Leifras is debuting on Nasdaq at $4 per ADS to raise $5M under ticker LFS. Find out if this Japanese micro-cap can attract global investors.
Is Hitachi’s OpenAI deal the breakthrough Japan needs to lead in global AI data center infrastructure?
Hitachi (TSE: 6501) teams with OpenAI on AI data centers, boosting stock nearly 10%. See how energy, cooling, and Lumada integration shape its future.
DXB rockets on Japan orphan drug win — can Dimerix finally deliver an FSGS breakthrough?
Dimerix (ASX: DXB) secures orphan drug designation in Japan for DMX-200, strengthening its global Phase 3 kidney trial program. Find out what’s next.
Japan’s manufacturing shock: Why September’s slump is the steepest in six months
Japan’s manufacturing PMI dropped to its lowest in six months in September. Find out what drove the slump and what it means for investors today.
Why Accenture’s acquisition of Aidemy could reshape Japan’s AI reskilling landscape
Discover how Accenture’s acquisition of Aidemy reshapes its AI reskilling strategy and what this means for enterprise digital transformation today.
Can Zimmer Biomet’s new iodine-coated iTaperloc and iG7 systems change infection prevention in hip surgery?
Zimmer Biomet wins Japan approval for the world’s first iodine-treated hip implant, reshaping infection prevention in orthopedics.
Asia markets split: Why Japan and South Korea surged while Hong Kong lagged after Wall Street’s record rally
Asia stocks diverged as Japan and South Korea surged while Hong Kong lagged after Wall Street highs. See what drove the split and what to watch next.
Lam Research and JSR Corporation cross-licensing deal: what it means for semiconductor innovation in the AI era
Lam Research and JSR Corporation team up to advance EUV and dry resist technology, resolving litigation and driving AI-focused semiconductor innovation.
Why Japan’s review of Ferring’s bladder cancer gene therapy candidate could reshape urology
Discover how Ferring’s gene therapy nadofaragene firadenovec could transform NMIBC treatment in Japan after PMDA NDA acceptance.
Zinzino accelerates North American and Japanese growth with Bodē Pro acquisition
Zinzino acquires Bodē Pro to expand its direct sales wellness footprint in North America and Japan, aiming to accelerate growth and boost market share.